Search

Your search keyword '"Joao Eurico Fonseca"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Joao Eurico Fonseca" Remove constraint Author: "Joao Eurico Fonseca"
64 results on '"Joao Eurico Fonseca"'

Search Results

1. Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge

2. The Phenotype of Mixed Connective Tissue Disease Patients Having Associated Interstitial Lung Disease

3. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

4. Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol

5. Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes

6. Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine

8. Hepatitis B vaccination associated with low response in patients with rheumatic diseases treated with biologics

9. Let’s review the gut microbiota in systemic lupus erythematosus

10. Different antibody-associated autoimmune diseases have distinct patterns of T follicular cell dysregulation

11. Spotlight on latent tuberculosis infection screening for juvenile idiopathic arthritis in two countries, comparing high and low risk patients

12. Predictors of cardiac involvement in idiopathic inflammatory myopathies

14. Symposium 7 How Much We Know about Pre-Clinical Rheumatoid Arthritis?

16. Golimumab (anti-TNF monoclonal antibody): where we stand today

17. [Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis]

18. Disease mechanisms in preclinical rheumatoid arthritis: A narrative review

19. Histopathology of Psoriatic Arthritis Synovium—A Narrative Review

20. Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal—A Multicenter, Nationwide Study

21. B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

22. Bone Phenotyping Approaches in Human, Mice and Zebrafish – Expert Overview of the EU Cost Action GEMSTONE ('GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork')

23. Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases

25. Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review

27. Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis

28. Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era

30. Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature

31. Atherosclerosis and Bone Loss in Humans–Results From Deceased Donors and From Patients Submitted to Carotid Endarterectomy

32. Arthroscopic Guided Synovial Biopsies

33. JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis

34. A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains

35. Celastrol Efficacy by Oral Administration in the Adjuvant-Induced Arthritis Model

36. A COVID-19 Outbreak in a Rheumatology Department Upon the Early Days of the Pandemic

37. Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view

39. Ultrasound and its clinical use in rheumatoid arthritis: where do we stand?

40. Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

41. Low Serum Levels of DKK2 Predict Incident Low‐Impact Fracture in Older Women

43. Anti-TNF Drugs for Chronic Uveitis in Adults—A Systematic Review and Meta-Analysis of Randomized Controlled Trials

44. Cell sources of inflammatory mediators present in bone marrow areas inside the meniscus.

45. Diet, Microbiota, and Gut Permeability—The Unknown Triad in Rheumatoid Arthritis

46. Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations

47. Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors: March 2008 update Recomendações para o diagnóstico e tratamento das tuberculoses latente e activa nas doenças inflamatórias articulares candidatas a terapêutica com fármacos inibidores do factor de necrose tumoral alfa: Revisão de Março de 2008

48. Reuma.pt – a case study

50. Guia prático de utilização de terapêuticas de biotecnologia na artrite reumatóide

Catalog

Books, media, physical & digital resources